Much as in the world of artificial intelligence, 2025 has begun on a high note for Chinese companies in biotech, with global interest in their work never greater. An announcement from Keymed Biosciences on a deal made with Timberlyne Therapeutics…
Originalartikel lesen: U.s.-china Drugs Tie-ups Come Under Threat – The Wire China
